Related Experiment Video

Updated: Jun 20, 2026

Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model
05:52

Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model

Published on: November 4, 2021

[Myocardial infarction aborted by rapid percutaneous coronary intervention]

Jeroen van Etten1, Freek W A Verheugt

  • 1Onze Lieve Vrouwe Gasthuis, afd. Cardiologie, Amsterdam, The Netherlands.

Nederlands Tijdschrift Voor Geneeskunde
|September 30, 2009
PubMed

Insights

Percutaneous coronary intervention with stenting may abort ST segment elevation myocardial infarction. This case series suggests PCI can normalize ECGs and limit cardiac enzyme release, offering promising results for acute myocardial infarction treatment.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • ST segment elevation myocardial infarction (STEMI) is a critical condition requiring rapid reperfusion.
  • Fibrinolysis is an established treatment for aborting myocardial infarction.
  • The efficacy of percutaneous coronary intervention (PCI) in aborting myocardial infarction remains less proven.

Observation:

  • Two patients (55-year-old woman, 51-year-old man) presented with STEMI confirmed by electrocardiogram (ECG).
  • Both patients underwent successful percutaneous coronary intervention with stenting.
  • Rapid reperfusion therapy was administered to both individuals.

Findings:

  • The ECG abnormalities normalized in both patients post-PCI.
  • No significant cardiac enzyme abnormalities were detected in the blood after treatment.
  • These outcomes suggest a potential for PCI to abort myocardial infarction.

Implications:

  • PCI with stenting may be an effective strategy for aborting acute myocardial infarction.
  • These findings warrant further investigation in larger clinical trials.
  • Successful reperfusion via PCI could improve patient outcomes in STEMI.

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Myocardial Infarction and Functional Outcome Assessment in Pigs12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...